Vanguard Group’s Rennova Health, Inc. RNVA Stock Holding History

Vanguard Group’s Portfolio RNVA Stock Details RNVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-887	Closed	-$24K	–	4091
2017 Q1	$24K	Hold	887	–	–	﹤0.01%	4051
2016 Q4	$33K	Buy	887 +133	+18%	+$7.55K	﹤0.01%	4053
2016 Q3	$64K	Buy	+754	New	+$99K	﹤0.01%	4016
2015 Q4	–	Sell	-9	Closed	-$27K	–	4208
2015 Q3	$27K	Hold	9	–	–	﹤0.01%	4167
2015 Q2	$27K	Buy	+9	New	+$33.8K	﹤0.01%	4177

Other funds holding RNVA

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Group's RNVA Position: Q2 2017 in Review

Vanguard Group sold out of Rennova Health, Inc. (RNVA) in Q2 2017, closing a stake of 887 shares — an estimated $24K sold.

Vanguard Group first reported a position in RNVA in Q2 2015 and held it in 5 quarters. The position peaked at $64K in Q3 2016. 8 funds tracked by Wall St. Rank hold RNVA as of Q2 2017.

Vanguard Group reported no remaining Rennova Health, Inc. position as of Q2 2017 after selling out during the quarter.
Vanguard Group sold 887 Rennova Health, Inc. shares in Q2 2017, an estimated $24K.
Vanguard Group first reported a position in Rennova Health, Inc. in Q2 2015 and held it in 5 quarters.
Vanguard Group's Rennova Health, Inc. position peaked at $64K in Q3 2016.
8 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q2 2017.

Based on Vanguard Group's 13F filing for Q2 2017, filed 11 Aug 2017.